EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer

Monique de Fatima Mello Santana iD, Maria Isabela Bloise Alves Caldas Sawada iD, Aritania Sousa Santos, Mozania Reis, Jacira Xavier, Maria Lúcia Côrrea-Giannella iD, Andrea Harumy de Lima Hirata iD, Luiz Henrique Gebrim, Francisco Garcia Soriano, Cleber Pinto Camacho iD, Marisa Passarelli iD

International Journal of Molecular Sciences · 14.08.2023 · 24 (16) · 12762

DOI: 10.3390/ijms241612762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.08.2023. Verfasst von Monique de Fatima Mello Santana und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Lípides (LIM 10), Hospital das Clínicas (HCFMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression of inflammation-related miRs bound to high-density lipoproteins (HDLs), the anti-inflammatory activity of HDLs isolated from individuals with breast cancer, and controls were determined. Forty newly diagnosed women with breast cancer naïve of treatment and 10 control participants were included. Cholesterol-loaded bone-marrow-derived macrophages were incubated with HDL from both groups and challenged with lipopolysaccharide (LPS). Interleukin 6 (IL6) and tumor necrosis factor (TNF) in the medium were quantified. The miRs in HDLs were determined by RT-qPCR. Age, body mass index, menopausal status, plasma lipids, and HDL composition were similar between groups. The ability of HDL to inhibit IL6 and TNF production was higher in breast cancer compared to controls, especially in advanced stages of the disease. The miR-223-3p and 375-3p were higher in the HDLs of breast cancer independent of the histological type of the tumor and had a high discriminatory power between breast cancer and controls. The miR-375-3p was greater in the advanced stages of the disease and was inversely correlated with the secretion of inflammatory cytokines. Inflammation-related miRs and the anti-inflammatory role of HDLs may have a significant impact on breast cancer pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsHumansFemaleInterleukin-6Anti-Inflammatory AgentsInflammationLipoproteins, HDLTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

HDLbreast cancerinflammationmicroRNAplasma lipids

Substanzen

Interleukin-6MicroRNAsAnti-Inflammatory AgentsLipoproteins, HDLTumor Necrosis Factor-alphaMIR223, humanMIRN375 microRNA, human

Autor:innen und Institutionen

  • Laboratório de Lípides (LIM 10), Hospital das Clínicas (HCFMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
  • Programa de Pós-Graduação em Medicina, Universidade Nove de Julho (UNINOVE), São Paulo 01525-000, Brazil.
  • Hospital da Força Aérea de São Paulo, São Paulo 02012-021, Brazil.
  • Laboratório de Carboidratos e Radioimunoensaio (LIM 18), Hospital das Clínicas (HCFMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
  • Unidade Básica de Saúde Dra. Ilza Weltman Hutzler, São Paulo 02472-180, Brazil.
  • Centro de Referência da Saúde da Mulher-Hospital Pérola Byington, São Paulo 01215-000, Brazil.

ORCID-Profile: Monique de Fatima Mello Santana, Maria Isabela Bloise Alves Caldas Sawada, Maria Lúcia Côrrea-Giannella, Andrea Harumy de Lima Hirata, Cleber Pinto Camacho, Marisa Passarelli

Förderung

  • São Paulo Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Santana, M. F. M., Sawada, M. I. B. A. C., Santos, A. S., Reis, M., Xavier, J., Côrrea-Giannella, M. L., Hirata, A. H. L., Gebrim, L. H., Soriano, F. G., Camacho, C. P., & Passarelli, M. (2023). Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. International Journal of Molecular Sciences, 24(16), 12762. https://doi.org/10.3390/ijms241612762

Vancouver

Santana MFM, Sawada MIBAC, Santos AS, Reis M, Xavier J, Côrrea-Giannella ML, et al. Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. International Journal of Molecular Sciences. 2023;24(16):12762. doi:10.3390/ijms241612762

BibTeX
@article{Santana2023,
  author = {Santana, Monique de Fatima Mello and Sawada, Maria Isabela Bloise Alves Caldas and Santos, Aritania Sousa and Reis, Mozania and Xavier, Jacira and Côrrea-Giannella, Maria Lúcia and Hirata, Andrea Harumy de Lima and Gebrim, Luiz Henrique and Soriano, Francisco Garcia and Camacho, Cleber Pinto and Passarelli, Marisa},
  title = {Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12762},
  doi = {10.3390/ijms241612762}
}
Kostenlos starten →